All In Biotech

Free tool

FAERS Monitor: Herceptin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103792 or its brand name (Herceptin, Trastuzumab). Reports on generic versions are filed under their own applications.

Reports

68,519

Serious

58,724

86% of reports

Hospitalization

19,884

Death reported

8,254

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea6,727
  • alopecia5,032
  • nausea4,582
  • fatigue4,414
  • off label use4,273
  • death3,634
  • disease progression3,611
  • myelosuppression3,242
  • vomiting3,054
  • dyspnoea2,795
  • pyrexia2,541
  • asthenia2,348
  • neutropenia2,209
  • neuropathy peripheral2,161
  • pain2,068

Reports by year received

View as table
YearReports
2004372
2005377
2006529
2007587
2008654
2009973
20101,225
20111,190
20122,644
20132,889
20142,389
20152,682
20162,839
20174,453
20185,684
20194,963
20205,107
20214,903
20224,743
20235,016
20246,903
20254,330
20263,067

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,985,640 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal3,24230.329.283,599
disease progressionSignal3,6119.69.327,224
alopeciaSignal5,0328.07.830,531
neuropathy peripheralSignal2,1617.16.811,138
neutropeniaSignal2,2095.14.87,106
diarrhoeaSignal6,7273.23.110,522
pyrexiaSignal2,5412.32.21,807
vomitingSignal3,0542.01.91,552
asthenia2,3481.91.81,051
nausea4,5821.81.71,622
fatigue4,4141.71.71,448
dyspnoea2,7951.51.5505
off label use4,2731.51.5740
death3,6341.31.3255
pain2,0681.01.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.